Is Ginkgo Sleep Quality Randomized Trial safe?

Updated July 2026

Quick Answer

Ginkgo Sleep Quality Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Conclusion Current RCT evidence shows inconsistent and limited findings, and no firm conclusions can be drawn about whether any OTC therapy provides symptomatic benefit.

Key Takeaways

  • 01Conclusion Current RCT evidence shows inconsistent and limited findings, and no firm conclusions can be drawn about whether any OTC therapy provides symptomatic benefit. [Menon R (2026)]
  • 02Level of evidence 1 (Systematic review of RCTs with low-moderate heterogeneity). [Menon R (2026)]
  • 03Objective To review the effectiveness of over-the-counter (OTC) treatments in reducing tinnitus symptom severity as measured by the Tinnitus Handicap Inventory (THI) in randomized controlled trials. [Menon R (2026)]
  • 04Methods A comprehensive search was conducted in PubMed, Embase, Cochrane CENTRAL, ClinicalTrials.gov, and WHO ICTRP through March 2025. [Menon R (2026)]
The current Migaku evidence database contains 2 reusable source documents for Ginkgo Sleep Quality Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Conclusion Current RCT evidence shows inconsistent and limited findings, and no firm conclusions can be drawn about whether any OTC therapy provides symptomatic benefit. [Menon R (2026); evidence level 1] - Level of evidence 1 (Systematic review of RCTs with low-moderate heterogeneity). [Menon R (2026); evidence level 1] - Objective To review the effectiveness of over-the-counter (OTC) treatments in reducing tinnitus symptom severity as measured by the Tinnitus Handicap Inventory (THI) in randomized controlled trials. [Menon R (2026); evidence level 1] - Methods A comprehensive search was conducted in PubMed, Embase, Cochrane CENTRAL, ClinicalTrials.gov, and WHO ICTRP through March 2025. [Menon R (2026); evidence level 1] - These limitations have catalyzed an increased global focus on nutraceuticals and phytomedicines possessing multimodal biological activities that transcend mere monoamine reuptake inhibition. [Li Xikun (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Effectiveness of Over-The-Counter Treatments for Tinnitus Symptom Relief: A Systematic Review.
  2. Rhodiola rosea , Ginkgo biloba , and Ashwagandha as novel antidepressant supplements: converging monoaminergic, neurotrophic, anti-inflammatory, and brain health pathways in depressive disorders